Neonatal Sepsis is Reduced by IV Antibiotics in Preterm PROM
The primary neonatal complication reduced by IV antibiotics in this clinical scenario is sepsis (Option A). 1, 2, 3, 4
Evidence Supporting Sepsis Reduction
The CDC guidelines explicitly state that intrapartum antibiotic prophylaxis reduces vertical transmission of Group B Streptococcus and provides 86-89% effectiveness in preventing early-onset neonatal sepsis among infants born to women who received prophylaxis. 1
For preterm premature rupture of membranes (PPROM) specifically:
Antibiotics are strongly recommended (GRADE 1B) for PPROM ≥24 weeks gestation to reduce neonatal morbidity, including sepsis. 2
A meta-analysis of seven randomized trials demonstrated that antibiotic therapy significantly reduced neonatal sepsis risk by 68% (odds ratio 0.32,95% CI 0.16-0.65, p=0.001) in preterm PROM cases. 4
A prospective randomized study of 733 patients showed neonatal sepsis was significantly lower in the antibiotics group (1 case vs. 7 cases, p<0.007). 3
Why Other Options Are Incorrect
Retinopathy of prematurity (Option B): No evidence links antibiotic administration to reduction in retinopathy. This condition is primarily related to oxygen exposure and prematurity itself. 1, 2
Intracranial hemorrhage (Option C): While one meta-analysis showed antibiotics reduced intraventricular hemorrhage by 50% in PPROM, 4 this finding is less consistently demonstrated across guidelines compared to sepsis reduction. The CDC guidelines do not emphasize hemorrhage prevention as a primary benefit of antibiotics. 1
Respiratory distress syndrome (Option D): The meta-analysis found no significant effect of antibiotics on RDS (odds ratio 0.84,95% CI 0.58-1.22). 4 RDS prevention requires antenatal corticosteroids, not antibiotics. 1
Clinical Application for This Case
At 33 weeks gestation with ruptured membranes:
Immediate GBS prophylaxis is mandated regardless of known colonization status, using IV penicillin, ampicillin, or cefazolin. 1, 2
The standard regimen is IV ampicillin and erythromycin for 48 hours, followed by oral therapy for 5 days (total 7-day course). 2
This approach specifically targets prevention of early-onset neonatal sepsis, which has the strongest evidence base. 1, 3, 4